Successful treatment of choroidal neovascular membrane in retinitis pigmentosa with intravitreal bevacizumab

International Ophthalmology

Volumn 30, Issue 4, 2010, Pages 425-428

  Malik, Archana ^a   Sood, Sunandan ^a   Narang, Subina ^a  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Anti VEGF; Bevacizumab; Choroidal neovascular membrane; Retinitis pigmentosa

Indexed keywords

BEVACIZUMAB; VASCULOTROPIN ANTIBODY; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CASE REPORT; COMORBIDITY; DISEASE DURATION; ELECTRORETINOGRAM; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; REMISSION; RETINA DETACHMENT; RETINA DYSTROPHY; RETINITIS PIGMENTOSA; SCAR FORMATION; SINGLE DRUG DOSE; SUBRETINAL NEOVASCULARIZATION; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION; CHOROIDAL NEOVASCULARIZATION; COMPLICATION; EYE FUNDUS; INTRAOCULAR DRUG ADMINISTRATION; TREATMENT OUTCOME; VITREOUS BODY;

ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; FUNDUS OCULI; HUMANS; INJECTIONS, INTRAOCULAR; MALE; RETINITIS PIGMENTOSA; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VITREOUS BODY; ANTIBODIES, MONOCLONAL, HUMANIZED;

EID: 77956181654     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10792-009-9337-4     Document Type: Article

References (11)

1. Bressler NM, Bressler SB, Fine SL (2005) Neovascular (exudative) age related macular degeneration. In: Ryan SJ (ed) Retina, 4th edn. Elsevier Mosby, St. Louis, pp 1075-1111
2. Marano F, Deutman AF, Leys A, Aandekerk AL (2000) Hereditary retinal dystrophies and choroidal neovascularization. Graefés Arch Clin Exp Ophthalmol 238:760-764
3. Iwakiri R, Okinami S, Hirata A (2007) Two cases of retinitis pigmentosa associated with choroidal neovascularisation. Nippon Ganka Gakkai Zasshi 111:606-611
4. Treatment of Age-related Macular Degeneration With Photodynamic Therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Arch Ophthalmol 117:1329-1345
5. Reichel E, Berrocal AM, Ip M, Kroll AJ, Duker JS, Puliafito CA (1999) Transpupillary thermotherapy of occult choroidal neovascularization in patients with agerelated macular degeneration. Ophthalmology 106:1908-1914
6. Bergink GJ, Deutman AF, Van Daal WAJ (1992) Radiation therapy for subfoveal choroidal neovascular membranes in age-related macular degeneration: a pilot study. Int Ophthalmol 16:16
7. Fung WE (1991) Interferon alpha 2a for treatment of agerelated macular degeneration. Am J Ophthalmol 112:349-350
8. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ (2006) Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113:363-372
9. Chan WM, Lai TY, Liu DT, Lam DS (2007) Intravitreal bevacizumab (avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study. Ophthalmology 114:2190-2196
10. Chan WM, Lai TY, Liu DT, Lam DS (2007) Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol 143:977-983
11. Leu J, Schrage NF, Degenring RF (2007) Choroidal neovascularisation secondary to Best́s disease in a 13-yearold boy treated by intravitreal bevacizumab. Graefés Arch Clin Exp Ophthalmol 245:1723-1725